| Morris W. Levinsohn, M.d., Inc. | |
|
4212 State Route 306 204 Willoughby OH 44094-9258 | |
| (440) 946-6725 | |
| (440) 946-3526 |
| Full Name | Morris W. Levinsohn, M.d., Inc. |
|---|---|
| Speciality | Psychiatry & Neurology |
| Location | 4212 State Route 306, Willoughby, Ohio |
| Authorized Official Name and Position | Morris W Levinsohn (PRESIDENT) |
| Authorized Official Contact | 4409466725 |
| Accepts Medicare Insurance | Yes. This clinic participates in medicare program and accept medicare insurance. |
| Mailing Address | Practice Location Address |
|---|---|
| Morris W. Levinsohn, M.d., Inc. 4212 State Route 306 204 Willoughby OH 44094-9258 Ph: (440) 946-6725 | Morris W. Levinsohn, M.d., Inc. 4212 State Route 306 204 Willoughby OH 44094-9258 Ph: (440) 946-6725 |
| NPI Number | 1528172632 |
|---|---|
| Provider Enumeration Date | 08/18/2006 |
| Last Update Date | 08/18/2009 |
| Medicare PECOS PAC ID | 9436253903 |
|---|---|
| Medicare Enrollment ID | O20070323000151 |
News Archive
Testing the safety of chemicals ranging from pesticides to household cleaners will benefit from new technologies and a plan for collaboration, according to federal scientists from the National Institutes of Health (NIH) and the U.S. Environmental Protection Agency (EPA), who today announced a new toxicity testing agreement.
Nanosystems that deliver anticancer drugs or imaging materials to tumors are showing significant progress, particularly those that respond to tumor-related stimuli, according to a review published in the journal Science and Technology of Advanced Materials.
For years, researchers and patients have hoped that embryonic stem cells (ESCs)-capable of forming nearly any cell type in the body-could provide insight into numerous diseases perhaps even be used to treat them. Yet progress has been hampered by the inability to transfer research and tools from mouse ESC studies to their human counterparts, in part because human ESCs are "primed" and slightly less plastic than the mouse cells.
Intellipharmaceutics International Inc., today announced that the Food and Drug Administration (FDA) has accepted for filing its abbreviated new drug application (ANDA) for a generic version of the antidepressant Effexor XR® (venlafaxine hydrochloride).
She has been at the center of at least three public firestorms - for removing consumer protections in health insurance rules approved by her predecessor, for attending a campaign fund-raiser held by an insurance company and for suggesting that the Texas Windstorm Insurance Association raise premium rates.
› Verified 7 days ago
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1528172632 | NPI | - | NPPES |
| 2731548 | Medicaid | OH |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2084N0400X | Psychiatry & Neurology - Neurology | 35034958L (Ohio) | Primary |
| Provider Name | Morris W Levinsohn |
|---|---|
| Provider Type | Practitioner - Pediatric Medicine |
| Provider Identifiers | NPI Number: 1528042785 PECOS PAC ID: 8022007376 Enrollment ID: I20040511000795 |
News Archive
Testing the safety of chemicals ranging from pesticides to household cleaners will benefit from new technologies and a plan for collaboration, according to federal scientists from the National Institutes of Health (NIH) and the U.S. Environmental Protection Agency (EPA), who today announced a new toxicity testing agreement.
Nanosystems that deliver anticancer drugs or imaging materials to tumors are showing significant progress, particularly those that respond to tumor-related stimuli, according to a review published in the journal Science and Technology of Advanced Materials.
For years, researchers and patients have hoped that embryonic stem cells (ESCs)-capable of forming nearly any cell type in the body-could provide insight into numerous diseases perhaps even be used to treat them. Yet progress has been hampered by the inability to transfer research and tools from mouse ESC studies to their human counterparts, in part because human ESCs are "primed" and slightly less plastic than the mouse cells.
Intellipharmaceutics International Inc., today announced that the Food and Drug Administration (FDA) has accepted for filing its abbreviated new drug application (ANDA) for a generic version of the antidepressant Effexor XR® (venlafaxine hydrochloride).
She has been at the center of at least three public firestorms - for removing consumer protections in health insurance rules approved by her predecessor, for attending a campaign fund-raiser held by an insurance company and for suggesting that the Texas Windstorm Insurance Association raise premium rates.
› Verified 7 days ago
News Archive
Testing the safety of chemicals ranging from pesticides to household cleaners will benefit from new technologies and a plan for collaboration, according to federal scientists from the National Institutes of Health (NIH) and the U.S. Environmental Protection Agency (EPA), who today announced a new toxicity testing agreement.
Nanosystems that deliver anticancer drugs or imaging materials to tumors are showing significant progress, particularly those that respond to tumor-related stimuli, according to a review published in the journal Science and Technology of Advanced Materials.
For years, researchers and patients have hoped that embryonic stem cells (ESCs)-capable of forming nearly any cell type in the body-could provide insight into numerous diseases perhaps even be used to treat them. Yet progress has been hampered by the inability to transfer research and tools from mouse ESC studies to their human counterparts, in part because human ESCs are "primed" and slightly less plastic than the mouse cells.
Intellipharmaceutics International Inc., today announced that the Food and Drug Administration (FDA) has accepted for filing its abbreviated new drug application (ANDA) for a generic version of the antidepressant Effexor XR® (venlafaxine hydrochloride).
She has been at the center of at least three public firestorms - for removing consumer protections in health insurance rules approved by her predecessor, for attending a campaign fund-raiser held by an insurance company and for suggesting that the Texas Windstorm Insurance Association raise premium rates.
› Verified 7 days ago
Judith Marinich, Inc. Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 38039 W Spaulding St, Willoughby, OH 44094 Phone: 440-918-1806 Fax: 440-918-1807 | |
Associates In Neurology, Inc Mental Health Clinic Medicare: Medicare Enrolled Practice Location: 35040 Chardon Rd, Suite 110, Willoughby, OH 44094 Phone: 440-946-1200 Fax: 440-946-5186 | |
Signature Health Associates, Llc Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 38882 Mentor Ave, Willoughby, OH 44094 Phone: 440-953-9999 Fax: 440-918-3839 | |
Phoenix Counseling And Wellness, Llc Mental Health Clinic Medicare: Medicare Enrolled Practice Location: 35104 Euclid Ave Ste 306, Willoughby, OH 44094 Phone: 440-571-5009 Fax: 440-571-4850 | |
Jordan Community Residential Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 30841 Euclid Ave Ste 103, Willoughby, OH 44094 Phone: 216-441-2496 Fax: 216-634-9611 | |
Drs Feldman,svete,foerstner Llc Mental Health Clinic Medicare: Medicare Enrolled Practice Location: 34950 Chardon Rd Ste 202, Willoughby, OH 44094 Phone: 440-510-5100 Fax: 440-510-5151 | |
Signature Health, Inc Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 38882 Mentor Ave, Willoughby, OH 44094 Phone: 440-953-9999 Fax: 440-918-3839 |